Literature DB >> 15054577

[Hemoptysis].

L Freitag1, H N Macha.   

Abstract

Hemoptysis is a potentially life-threatening complication of various diseases. The most common causes are infectious and inflammatory processes, followed by neoplasms, pulmonary embolisms, mitral stenoses, coagulopathies, and multiple systemic disorders. Primary examinations include a chest x-ray, an angio CT and a bronchoscopy. Sometimes, a bronchial artery angiogram is required. The patient is at risk of suffocation because blood and clots can severely obstruct his airways. Thus, the most important measures are: supplemental oxygen, positioning the patient with the bleeding side down, bronchoscopical suctioning and removal of blood and clots. Coagulopathies have to be corrected. Application of vasoactive drugs may help temporarily. In cases of bleeding from central lesions, coagulation with laser or argon-plasma-coagulator is feasible. Heavy bleeding from the periphery requires a balloon or tube tamponade. Depending on the cause and the severity of the bleeding either anti-inflammatory medical treatment, hemostyptic radiation therapy, bronchial artery embolisation or a surgical procedure must follow.

Entities:  

Mesh:

Year:  2004        PMID: 15054577     DOI: 10.1007/s00108-004-1173-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  36 in total

1.  Management of life-threatening haemoptysis.

Authors:  E Håkanson; I E Konstantinov; S G Fransson; R Svedjeholm
Journal:  Br J Anaesth       Date:  2002-02       Impact factor: 9.166

2.  Endobronchial electrosurgery.

Authors:  V A Gerasin; B B Shafirovsky
Journal:  Chest       Date:  1988-02       Impact factor: 9.410

3.  Plastic endobronchial tubes in the management of life-threatening hemoptysis.

Authors:  U Shivaram; P Finch; P Nowak
Journal:  Chest       Date:  1987-12       Impact factor: 9.410

4.  Current strategy for surgical management of bronchiectasis.

Authors:  T Fujimoto; L Hillejan; G Stamatis
Journal:  Ann Thorac Surg       Date:  2001-11       Impact factor: 4.330

5.  Management and prognosis of massive hemoptysis. Recent experience with 120 patients.

Authors:  C J Knott-Craig; J G Oostuizen; G Rossouw; J R Joubert; P M Barnard
Journal:  J Thorac Cardiovasc Surg       Date:  1993-03       Impact factor: 5.209

6.  Does bronchography have a role in the assessment of patients with haemoptysis?

Authors:  D K Jones; P Cavanagh; J M Shneerson; C D Flower
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

7.  Management of acute pulmonary hemorrhage in children.

Authors:  J D Sidman; W B Wheeler; A K Cabalka; B Soumekh; C A Brown; G B Wright
Journal:  Laryngoscope       Date:  2001-01       Impact factor: 3.325

8.  Surgical management of invasive pulmonary aspergillosis in neutropenic patients.

Authors:  A Bernard; D Caillot; J F Couaillier; O Casasnovas; H Guy; J P Favre
Journal:  Ann Thorac Surg       Date:  1997-11       Impact factor: 4.330

9.  Thoracic endometriosis syndrome: new observations from an analysis of 110 cases.

Authors:  J Joseph; S A Sahn
Journal:  Am J Med       Date:  1996-02       Impact factor: 4.965

10.  Pulmonary resection for massive hemoptysis of benign etiology.

Authors:  Adel Ayed
Journal:  Eur J Cardiothorac Surg       Date:  2003-11       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.